| Literature DB >> 31847106 |
Tamara Pawlaczyk-Kamieńska1, Maria Borysewicz-Lewicka1, Halina Batura-Gabryel2.
Abstract
The mutation of cystic fibrosis transmembrane conductance regulator (CFTR) can modify the physical and chemical properties of saliva, which in turn can affect the oral microflora and oral health in patients with cystic fibrosis (CF). The aim of the study was to examine oral health status, salivary properties, and total oral bacteria count in CF adults. Dental status was assessed using the decayed missing filled surfaces (DMF-S) index, and oral clearness using the approximal plaque index (API). The Saliva-Check BUFFER test was used to assess saliva, and real-time polymerase chain reaction (PCR) test to determine the total oral bacteria count. CF patients in comparison to healthy controls showed a higher level of examined clinical indices, higher total oral bacteria count, lower salivary flow rate, lower salivary pH, and increased viscosity. Conclusions: In CF patients, saliva properties, accompanied by insufficient dental care, might be an essential dental caries risk factor. In CF patients, among the etiological factors for dental caries, the bacterial agent seems to be less significant. The frequent and long-term infectious pharmacotherapy can probably explain that. A great deal of the information collected on the oral environment in CF patients, which has helped us understand the etiological conditions for inflammation and infection in this area of the body, indicates that proper dental care can mostly counteract these pathologies.Entities:
Keywords: cystic fibrosis; oral health status; oral microbiota; salivary biomarkers
Year: 2019 PMID: 31847106 PMCID: PMC6955745 DOI: 10.3390/microorganisms7120692
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Age distribution in the studied subjects.
Oral health status and salivary parameters in cystic fibrosis patients and healthy controls.
| CF Patients | Control Group | ||||
|---|---|---|---|---|---|
| D-S > 0 | 19 (86.36) | 6 (27.27) | 0.0001 | ||
| M-S > 0 | 14 (63.63) | 7 (31.82) | 0.17 | ||
| F-S > 0 | 20 (90.91) | 19 (86.36) | 0.65 | ||
| API | <25% | 0 (0.00) | 1 (4.55) | 0.34 | |
| 25–39% | 1 (4.54) | 6 (27.27) | 0.03 | ||
| 40–70% | 5 (22.73) | 5 (22.73) | 0.98 | ||
| >70% | 16 (72.73) | 10 (45.45) | 0.07 | ||
| unstimulated saliva | flow rate | Normal | 11 (50.00) | 22 (100) | 0.0001 |
| Low | 11 (50.00) | 0 (0.00) | 0.0001 | ||
| consistency | normal viscosity | 3 (13.64) | 22 (100) | <0.0001 | |
| increased viscosity | 19 (86.36) | 0 (0.00) | <0.0001 | ||
| pH | Normal | 9 (40.91) | 16 (72.73) | 0.04 | |
| moderately acidic | 11 (50.00) | 5 (22.73) | 0.06 | ||
| highly acidic | 2 (9.09) | 1 (4.54) | 0.50 | ||
| stimulated saliva | volume/flow rate | Normal | 11 (50.00) | 22 (100) | 0.0001 |
| Low | 5 (22.73) | 0 (0.00) | 0.02 | ||
| very low | 6 (27.27) | 0 (0.00) | 0.009 | ||
| buffering capacity | Normal | 12 (57.14) * | 9 (40.91) | 0.29 | |
| Low | 7 (33.33) * | 13 (59.09) | 0.08 | ||
| very low | 2 (9.52) * | 0 (0.00) | 0.15 | ||
* buffering capacity was tested in 21 CF patient. Abbreviations: CF, cystic fibrosis; DMF-S, decayed missing filled surfaces; D-S, decayed surfaces; M-S, missing surfaces; F-S, filled surfaces; API, approximal plaque index.
Figure 2(A–F) Data comparison graphs of the results of Mann-Whitney tests between cystic fibrosis patients and healthy controls. Abbreviations: CF, cystic fibrosis; DMF-S, decayed missing filled surfaces; API, approximal plaque index
Figure 3(A,B) Spearman correlation analysis between the approximal plaque index (API) and salivary flow rate, and between the buffer capacity of stimulated whole saliva and salivary flow rate in cystic fibrosis (CF) patients.